These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 34519539)

  • 21. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.
    Lee CH; Pinho MP; Buckley PR; Woodhouse IB; Ogg G; Simmons A; Napolitani G; Koohy H
    Front Immunol; 2020; 11():579480. PubMed ID: 33250893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
    Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A ubiquitous bone marrow reservoir of preexisting SARS-CoV-2-reactive memory CD4
    Li J; Reinke S; Shen Y; Schollmeyer L; Liu YC; Wang Z; Hardt S; Hipfl C; Hoffmann U; Frischbutter S; Chang HD; Alexander T; Perka C; Radbruch H; Qin Z; Radbruch A; Dong J
    Front Immunol; 2022; 13():1004656. PubMed ID: 36268016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tonsils are major sites of persistence of SARS-CoV-2 in children.
    Lima TM; Martins RB; Miura CS; Souza MVO; Cassiano MHA; Rodrigues TS; Veras FP; Sousa JF; Gomes R; Almeida GM; Melo SR; Silva GCD; Dias M; Capato CF; Silva ML; Luiz VEDB; Carenzi LR; Zamboni DS; Jorge DMM; Cunha FQ; Tamashiro E; Anselmo-Lima WT; Valera FCP; Arruda E
    Microbiol Spectr; 2023 Sep; 11(5):e0134723. PubMed ID: 37737615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
    Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2020; 11():607918. PubMed ID: 33424856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.
    Jung MK; Shin EC
    Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-Avidity CD4
    Bacher P; Rosati E; Esser D; Martini GR; Saggau C; Schiminsky E; Dargvainiene J; Schröder I; Wieters I; Khodamoradi Y; Eberhardt F; Vehreschild MJGT; Neb H; Sonntagbauer M; Conrad C; Tran F; Rosenstiel P; Markewitz R; Wandinger KP; Augustin M; Rybniker J; Kochanek M; Leypoldt F; Cornely OA; Koehler P; Franke A; Scheffold A
    Immunity; 2020 Dec; 53(6):1258-1271.e5. PubMed ID: 33296686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytolytic CD8
    Allers K; Moos V; Hofmann J; Witkowski M; Haibel H; Angermair S; Schneider T
    Clin Immunol; 2023 Sep; 254():109712. PubMed ID: 37506745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8
    Kusnadi A; Ramírez-Suástegui C; Fajardo V; Chee SJ; Meckiff BJ; Simon H; Pelosi E; Seumois G; Ay F; Vijayanand P; Ottensmeier CH
    Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33478949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of SARS-CoV-2 and common cold coronavirus-specific T-cell responses in MIS-C and Kawasaki disease children.
    Hsieh LE; Grifoni A; Sidney J; Shimizu C; Shike H; Ramchandar N; Moreno E; Tremoulet AH; Burns JC; Franco A
    Eur J Immunol; 2022 Jan; 52(1):123-137. PubMed ID: 34599760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.
    Kingstad-Bakke B; Lee W; Chandrasekar SS; Gasper DJ; Salas-Quinchucua C; Cleven T; Sullivan JA; Talaat A; Osorio JE; Suresh M
    Proc Natl Acad Sci U S A; 2022 May; 119(20):e2118312119. PubMed ID: 35561224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19.
    Dang TTT; Anzurez A; Nakayama-Hosoya K; Miki S; Yamashita K; de Souza M; Matano T; Kawana-Tachikawa A
    Microbiol Spectr; 2023 Aug; 11(4):e0214323. PubMed ID: 37428088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.
    Giménez E; Albert E; Torres I; Remigia MJ; Alcaraz MJ; Galindo MJ; Blasco ML; Solano C; Forner MJ; Redón J; Signes-Costa J; Navarro D
    J Med Virol; 2021 Jan; 93(1):375-382. PubMed ID: 32579268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad and strong memory CD4
    Peng Y; Mentzer AJ; Liu G; Yao X; Yin Z; Dong D; Dejnirattisai W; Rostron T; Supasa P; Liu C; López-Camacho C; Slon-Campos J; Zhao Y; Stuart DI; Paesen GC; Grimes JM; Antson AA; Bayfield OW; Hawkins DEDP; Ker DS; Wang B; Turtle L; Subramaniam K; Thomson P; Zhang P; Dold C; Ratcliff J; Simmonds P; de Silva T; Sopp P; Wellington D; Rajapaksa U; Chen YL; Salio M; Napolitani G; Paes W; Borrow P; Kessler BM; Fry JW; Schwabe NF; Semple MG; Baillie JK; Moore SC; Openshaw PJM; Ansari MA; Dunachie S; Barnes E; Frater J; Kerr G; Goulder P; Lockett T; Levin R; Zhang Y; Jing R; Ho LP; ; ; Cornall RJ; Conlon CP; Klenerman P; Screaton GR; Mongkolsapaya J; McMichael A; Knight JC; Ogg G; Dong T
    Nat Immunol; 2020 Nov; 21(11):1336-1345. PubMed ID: 32887977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
    Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
    mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
    Cohen CA; Li APY; Hachim A; Hui DSC; Kwan MYW; Tsang OTY; Chiu SS; Chan WH; Yau YS; Kavian N; Ma FNL; Lau EHY; Cheng SMS; Poon LLM; Peiris M; Valkenburg SA
    Nat Commun; 2021 Jul; 12(1):4678. PubMed ID: 34326343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine.
    Chen Y; Yin S; Tong X; Tao Y; Ni J; Pan J; Li M; Wan Y; Mao M; Xiong Y; Yan X; Yang Y; Huang R; Wu C; Shen H
    Clin Microbiol Infect; 2022 Mar; 28(3):410-418. PubMed ID: 34715346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.